Evidence map›Paper›PMID 31423841›Full record

ReviewJournal of investigative medicine high impact case reports

Leptomeningeal Carcinomatosis From Carcinoma of Unknown Primary in a Young Patient: A Case Report and a Literature Review.

Leila Moosavi, Carlos D'Assumpcao, Jonathan Bowen, Arash Heidari, Everardo Cobos

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Leila Moosavi1 Kern Medical Center-UCLA, Bakersfield, CA, USA.ORCID 0000-0001-8790-910X
Carlos D'Assumpcao1 Kern Medical Center-UCLA, Bakersfield, CA, USA.ORCID 0000-0001-9967-9612
Jonathan Bowen2 Ross University, Miramar, FL, USA.
Arash Heidari1 Kern Medical Center-UCLA, Bakersfield, CA, USA.
Everardo Cobos1 Kern Medical Center-UCLA, Bakersfield, CA, USA.
Kern Medical Center · USCalifornia Miramar University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leptomeningeal carcinomatosis, leptomeningeal meningitis, or, as referred here, leptomeningeal metastasis (LM), is a rare but frequently fatal complication seen in advanced stage of cancer either locally advanced or after a metastasis of a known primary cancer. We present a rare and uncommon case of leptomeningeal metastases from carcinoma of unknown primary. A 32-year-old female was diagnosed with LM; however, no known primary carcinoma was identified after 2 separate biopsies. The first biopsy of the right pre-tracheal lymph node showed poorly differentiated pan-keratin (AE1 and AE3) and placental alkaline phosphatase with the possibility of germ cell origin. Second cytology of cervical lymphadenopathy was remarkable for cytokeratin 7 and 20, placental alkaline phosphatase, and CDX2 suggestive of germ line tumor with both mucinous ovarian and gastrointestinal carcinomas. Unfortunately, the LM progressed rapidly despite multiple cycles of germ cell origin directed systemic and intrathecal chemotherapy, and the patient opted for hospice care without getting a chance to identify the primary source.

Indexed as

Neoplasms, Unknown PrimaryAdultFemaleHumansMeningeal CarcinomatosisNeuroimagingTomography, X-Ray ComputedUltrasonographycarcinoma of unknown primarycaudal type homeobox 2cytokeratinleptomeningeal carcinomatosisleptomeningeal metastasisovarian mucinous carcinomaplacental alkaline phosphatase

Identifiers

PMID31423841
PMCPMC6699001
OpenAlexW2969038408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.